How America's prairie was nearly destroyed — and why it should be restored
The American prairie was so vast, so alien, it shattered comprehension.
Newcomers to the seemingly endless grasslands that once spanned approximately a quarter of North America often hit a psychic wall, descending into fits of mania. Prairie madness, as the phenomenon came to be known, was recorded by the journalist E.V. Smalley in 1893 after a decade of observing life on the frontier: 'An alarming amount of insanity occurs in the new Prairie States among farmers and their wives.'
America's treeless, isolated expanse put early European settlers to the test. Drought, loneliness, and debt drove many to failure, forcing the homesteaders to retreat East.
But those who stayed unwittingly launched one of history's largest terraforming projects, rewiring the land, the climate, and the future of the continent.
In Sea of Grass: The Conquest, Ruin, and Redemption of Nature on the American Prairie, longtime Minnesota journalists Dave Hage and Josephine Marcotty trace this staggering transformation.'The Europeans who colonized North America in the nineteenth century transformed the continent's hydrology as thoroughly as the glaciers,' they write. 'But, remarkably, they did it in less than one hundred years instead of tens of thousands.'
In putting hundreds of millions of acres of prairie to the plow, settlers not only forcibly displaced Indigenous nations, but completely altered the region's ancient carbon and nitrogen cycles. They also turned the region into an agricultural powerhouse. The deep black soil once prevalent in the Midwest — the result of thousands of years of animal and plant decomposition depositing untold carbon stores into the ground — became the foundation of the modern food system. But the undoing of the American prairie also dismantled one of the Earth's most effective climate defenses.
Grasses, like all plant life, inhale planet-warming carbon dioxide. As a result, 'earth's soils now contain one-third of the planet's terrestrial carbon — more than the total released by human activity since the start of the Industrial Revolution,' Hage and Marcotty write. A 2020 Nature study found that restoring just 15 percent of the world's plowed grasslands could absorb nearly a third of the carbon dioxide humans added to the atmosphere since the 1800s.
Today, the tallgrass prairie, which covered most of Illinois, Iowa, Minnesota, and the far eastern edge of the plains states, clings to about 1 percent of its former range. Even the hardier shortgrass prairie of the American West has been reduced by more than half.
'This is the paradox of the prairie,' the authors write. 'Feared by pioneers, shunned by tourists, dismissed today as a wasteland best viewed from thirty thousand feet, the North American prairie is nonetheless one of the richest ecosystems on Earth.'
Americans, then as now, have struggled to make sense of the prairie. Hage and Martcotty spoke to Grist about the near collapse of the American prairie, and what its return would mean in an era of a rapidly warming climate.
The prairie has been misunderstood at our own peril. Why is that and how do you make people care about grass?
Josephine Marcotty: When European settlers first arrived, they were terrified by the open spaces and by the crazy weather that they encountered on the prairie. Wide open grasslands were not something they had ever experienced in Europe, which had been much more controlled by humans for a longer period of time.
David Hage: The areas were so remote and a lot of these immigrants had come from sweet little villages in Norway or Sweden or Germany. Here, they landed, and they might not have a neighbor within 10 or 15 miles. People really suffered from terrible loneliness and even mental illness from the isolation.
JM: But by the time Americans realized that the prairie was something to preserve, the tallgrass prairie was almost all gone. It had been plowed and turned into farmland. So the tallgrass prairie is almost something that we've never experienced. We don't know what it is.
DH: We can talk about wildlife, we can talk about water, l but the thing that knocked me out is climate change. The world's grasslands are one of the planet's greatest buffers against climate change. When we plow open the grasslands, as we're doing now, a million acres a year out West, you're releasing huge amounts of carbon, you're making climate change worse, and you're taking out all those acres of grass that could sequester carbon in the future. One researcher we talked to, Tyler Lark, at the University of Wisconsin, said that the recent pace of plowing in the western grasslands is the climate change equivalent of adding 11 million cars to the roads every year. So it's a climate change disaster.
Early settlers didn't just plow the prairie. They also forcibly displace Native peoples to do it. How do you see large-scale prairie restoration as a means of reparations?
DM: We write about the bison herds out West on Native American reservations. There are now 25 or 30 of these wonderful tribal bison herds. This operation to rescue Yellowstone bison and distribute them to Native peoples has launched these tribal bison herds all the way from Alaska down to Texas. And it's a triple win: It saves this endangered, magnificent animal; it's good for the grasslands, because where bison graze, grass flourishes; and it's a wonderful way of preserving the threatened cultural heritage of the Plains tribes in South Dakota. There's also a great outfit called the Buffalo Grasslands Coalition, which is a tribal operation to raise money and restore grasslands and native ecosystems on tribe-managed land.
JM: A lot of the tribes have both a sacred herd that they use for their cultural and the religious ceremonies, and they also have livestock herds that they use to turn into meat that they sell, not only to their tribal members, but to others. It's having that economic independence that grants a stronger sense of sovereignty. You can't do it without economics.
The majority of the prairie is gone. Given its value, why does its destruction continue? Is it policy or profit or something else?
JM: Because corn pays more than cattle or bison.
DH: We came across an amazing statistic, that of all the major landscapes in America, grasslands were the last one to get their own national park. It didn't happen until 30 or 40 years ago, and one of the reasons was to protect that grass, they would be competing with farmers and people who wanted to earn a living on that land.
JM: The EPA just raised the ethanol fuel mandate. In other words, they're creating an even greater market for corn. And it was ethanol that really drove corn prices up, and they've been up ever since we started mandating the use of ethanol in fuel. That's just going to continue as long as we don't subsidize other kinds of farmers that actually grow food for us. Otherwise, grassland will never be able to compete.
The book makes the case that federal subsidies for ethanol have been disastrous for grasslands. Is it possible to dismantle a system that is both ecologically catastrophic and economically entrenched?
DH: It is a huge source of revenue for farmers in the Upper Midwest. We ran into a lot of farmers who said, 'I wouldn't be able to sell my corn crop if it weren't for ethanol,' or 'I didn't make any money until ethanol came along.' So it's very hard for politicians campaigning in the Midwest to stand up against ethanol. But it would only take very modest changes to the federal farm bill: Just wind down the ethanol mandate a bit, add a little more money to these proven federal conservation programs which reward farmers for conservation practices on working land.
JM: The economics are a false economy. It's all driven by federal policy and not markets.
DH: We met wonderful people in the course of reporting this book, generous, hard working people, but they're trapped in a system that's not of their own making. We have this federal set of subsidies that just pushes farmers in the direction of plowing more land, planting more corn, using more chemicals, and they don't have a lot of choice if they want to save the family farm and stay in business.
The book has an alternative vision for agriculture — one that saves soil and may even provide a lifeline for the prairie. What does that look like and where is it happening?
JM: It's going to be different wherever you farm. It's a lot easier to grow cover crops in southern Iowa than it is in North Dakota, simply because of the difference in the weather. A big piece here would be for farmers to plant more diverse crops. Nature does not like simplicity. Nature likes complexity, and if we had a more complex farm system, it would be better for everyone.
DH: There's really good research coming out of Iowa State University and the University of Minnesota, which shows that when you have a slightly more diverse crop rotation, you have less flooding, less erosion, healthier soil, less diesel fuel and less fossil fuel-based fertilizers.
This story was originally published by Grist with the headline How America's prairie was nearly destroyed — and why it should be restored on Jun 17, 2025.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Newsweek
26 minutes ago
- Newsweek
Scientists Reveal Healthiest Way of Drinking Coffee
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Good news for coffee purists—taking your joe black is associated with a reduced risk of death from all causes. This is the conclusion of a new study out of Tufts University, which found that this apparent benefit of coffee vanishes as cream, milk and sugar are added. "Coffee is among the most-consumed beverages in the world," said paper author and epidemiologist Fang Fang Zhang in a statement. "With nearly half of American adults reporting drinking at least one cup per day, it is important for us to know what it might mean for health." "The health benefits of coffee might be attributable to its bioactive compounds, but our results suggest that the addition of sugar and saturated fat may reduce the mortality benefits." Cups of coffee on a table. Cups of coffee on a table. Getty Images In their study, Zhang and colleagues analyzed health and diet data on a nationally-representative sample of 46,000 adults collected between 1999 and 2018. They linked this dataset to mortality data from the National Death Index to explore how different ways of taking one's coffee might affect one's risk of an early death. Specifically, the team categorized coffee consumption based on whether the drink was caffeinated or decaffeinated; taken with or without various forms of sugar; and whether it was drunk with or without milk, cream or half-and-half. The researchers also looked at how much sugar or saturated fats, respectively, were added to the subjects' coffee—with low added sugar (whether as granulated sugar, honey or syrup) and saturated fats being each classified as under 5 percent of the Daily Value. So, for example, this would be less than half a teaspoon of sugar and either give tablespoons of 2 percent milk or one tablespoon of either cream or half-and-half. The analyses indicated that consumption of at least one cup of caffeinated coffee per day was associated with a 16 percent lower risk of all-cause mortality—a figure that rose to 17 percent when 2–3 cups were consumed daily. Drinking more beyond this was not linked to further increases—in fact, drinking more than three cups a day appeared to weaken the benefit as concerned death from cardiovascular disease in particular. Moreover, the team found that the apparent health benefits of coffee were diminished when things were added to coffee. All-in-all, drinking black coffee and coffee with low levels of added sugar and saturated fat was associated with a 14 percent reduction in the risk of all-cause mortality, as compared to those people who didn't drink coffee. But that same link was not observed for coffee with high amounts of either added sugar or saturated fat. Paper author and nutrition epidemiologist Bingjie Zhou added: "Our results align with the Dietary Guidelines for Americans, which recommend limiting added sugar and saturated fat." Although the findings are likely to delight regular coffee drinkers, the study has some limitations—including how the data was based on people self-reporting how much coffee they drank, as well as how they took it. The team also noted that they did not find an association between the drinking of decaffeinated coffee and the risk of an early death—but cautioned that such might just be an artefact of how few of the subjects drank decaf. Do you have a tip on a science story that Newsweek should be covering? Do you have a question about coffee? Let us know via science@ Reference Zhou, B., Ruan, M., Pan, Y., Wang, L., & Zhang, F. F. (2025). Coffee Consumption and Mortality among United States Adults: A Prospective Cohort Study. The Journal of Nutrition.


National Geographic
an hour ago
- National Geographic
Axolotl
Scientific Name: Ambystoma mexicanum Average Life Span In The Wild: 10 to 15 years Size relative to a teacup: According to legend, the axolotl is the Aztec god of fire and lightning, Xolotl, who disguised himself as a salamander to avoid being sacrificed. But these amphibians are impressive enough on their own. Axolotls (pronounced ACK-suh-LAH-tuhl) can regenerate lost limbs and have a life cycle that allows them to stay 'young' their whole lives, a phenomenon called neoteny. Their youthful traits include feathery gills sprouting from their heads like a mane, webbed feet, a dorsal fin that runs down the length of their body, and a tail. Though they keep these external gills, adults also have functional lungs and can breathe through their skin. And as if being forever-babies didn't make them cute enough, they wear a permanent Mona Lisa smile. A popular oddity These cute critters have long fascinated the public, even more so when they were first brought from Mexico to Paris in 1864. Europeans across the continent began breeding them. That began a robust pet trade in the animals, which breed easily in captivity. In the wild, they're mostly grayish-brown in color. Lighter colored specimens, especially those with white bodies and pink gills, are usually bred as pets. Yet in most countries, axolotls cannot be traded across international borders, partly because of poaching concerns. They're illegal to own in some parts of the United States for the same reason. Some are also concerned that they may escape captivity and interbreed with native salamanders. Thanks to their regenerative abilities, axolotls are a common research subject for biologists. They can regrow lost or damaged limbs, hearts, spinal cords, and even parts of their brains—all without permanent scarring. Since scarring prevents tissue from regenerating, finding out how and why axolotls don't scar could unlock human's ability to regenerate tissue. One study deciphered how the axolotl's molecules communicate to promote regeneration. A 2025 study may have cracked the code. A particular enzyme and gene work with retinoic acid to grow the right body part in the right spot. (Scientists may have found the key to amphibian regeneration.) Axolotl reproduction and behavior Axolotls are solitary creatures, but they reach sexual maturity at a year old. Their spawning season in the wild is in February. Males seek out females, possibly using pheromones, and perform a courtship 'hula' dance. He shakes his tail and lower body. She responds by nudging him with her snout. The male then deposits spermatophores, or sperm packets, on the lake floor, which the female picks up with her cloaca, a body cavity, and fertilizes her eggs. Females can lay up to a thousand eggs (though the average is about 300) on plant material or rocks, which protects them from predators. After two weeks, they hatch and, with no parental care, the larvae are off and swimming on their own. There's a theory for why axolotls don't change appearance as adults. Because their native lakes never dry up, as is the case for many other water bodies, axolotls didn't have to trade in their aquatic traits, such as a tadpole-like tail, for terrestrial ones, such as legs. (Axolotls and capybaras are TikTok famous—and that could be a problem.) Axolotl habitat and diet These lentic amphibians live and breed in Lake Xochimilco and Lake Chalco, located just south of Mexico City. During the day, axolotls hide from predators by burrowing in the mud or hanging out among aquatic plants. They become active at night, when their sweet little smiles quickly turn into vacuum cleaners. Axolotls suck in their prey, which includes crustaceans, mollusks, insect eggs, and small fish. They may also suck up gravel, which can help grind up the food in their belly. Conservation and threats An assessment by the International Union for the Conservation of Species found that only 50 to a thousand axolotls are left in the wild. And their numbers are dropping. They once inhabited the high-altitude lakes around Mexico City, but habitat degradation has limited them to a few inland canals in the area. Further habitat loss from tourism and residential housing development, in addition to agricultural and industrial pollution, have drastically reduced the axolotl population. So has the introduction of tilapia and other invasive fish species, which eat baby salamanders and compete with adults for food. The Mexican government, as well as many nonprofits, are trying to save Mexican axolotls, in part by restoring parts of their freshwater natural habitat and offering ecotourism for people to see the quirky salamanders in the wild. For instance, Luis Zambrano, a leading axolotl researcher at the National Autonomous University of Mexico, is working with scientists and farmers to create chinampas, floating islands made of water plants, logs, and lake mud that help filter the polluted water. Some travel companies offer tours of these gardens, whose proceeds support axolotl conservation efforts in the area. (Here's how farmers and scientists are saving the axolotl in Mexico City.) Fascinating facts about axolotls (Learn how Mexican nuns are helping to save axolotls.) See axolotls in the wild According to legend, this 'water monster' was a god who disguised himself as a salamander to avoid sacrifice. Nowadays, it is critically endangered in the wild because of the pollution and urban sprawl that threaten its habitat in the Mexican Basin. Is it OK to have an axolotl as a pet? You can legally own one from a reputable breeder, supplier, or rescue organization. Some states in America prohibit owning even legally obtained exotic pets or require a permit. Axolotls bred in captivity are typically pink or white, instead of brown. —World Wildlife Fund Why can't you touch axolotls? In general, you should not touch or handle axolotls unnecessarily. Their delicate skin is permeable, which means anything from natural oils to soap residue can cause harm. Additionally, their bodies are primarily made of cartilage, making them highly vulnerable to injury. —Environmental Literacy Council Do axolotls live in the U.S.? They are not native to the United States. They are endemic to southern Mexico City, in Xochimilco and Chalco Lakes. —The Natural History Museum U.K. Why did my axolotl turn into a salamander? It is extremely rare for wild axolotls to turn into salamanders. Environmental changes can cause a transformation and certain genetic traits can make some animals more prone to metamorphosis. In captivity, iodine or thyroid hormones can induce metamorphosis. However, doing so can cause stress and shorten the life of these fragile creatures, leading to ethical questions. Experts strongly discourage inducing metamorphosis. —Environmental Literacy Council Do axolotls have teeth? Yes, they have small, underdeveloped teeth. However, they eat by sucking in food. —PBS This story originally published on September 10, 2010. It was updated on June 17, 2025.


Politico
2 hours ago
- Politico
BIO chair: U.S. has a ‘crisis' on drug costs
Driving The Day NEW BIO CHAIR'S POLICY TAKE — The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump's second term. One of its chief lobbying arms is gearing up to take them on. Ahead of the Biotechnology Innovation Organization's annual convention this week in Boston, Genentech's Fritz Bittenbender — who was elected Monday as the group's board chair — chatted with Lauren about BIO's priority issues, distrust in science and medical institutions and its approach to geopolitical engagement. Pros can read the full Q&A, but here are some highlights and outtakes: An 'existential policy crisis': Bittenbender used the term to refer to debates around 'intellectual property, how do you pay for medicines, what kind of investments are we going to make at early-stage research' — all of which bring to mind Trump administration priorities like the most-favored-nation approach to bringing down drug prices and limiting National Institutes of Health spending on indirect costs in university research. 'We have a lot of sound-bite policy happening right now, and [most-favored-nation is] a great example of that,' he said, adding that the U.S. health system works much differently from those in allied European countries, often held up as examples of cheaper markets. How industry can combat distrust in science: Biotechs need to do a better job of communicating the benefits they bring to patients, and they need policymakers' help, Bittenbender said. 'Working with policymakers, and … bringing as much transparency to our industry as we possibly can — using real-world data and digital analytics more effectively to understand postmarketing studies of products on the market and being transparent about that,' he said. Federal job cuts: Regulatory uncertainty is an 'existential threat' to the industry amid the massive downsizing and restructuring of the Department of Health and Human Services, Bittenbender said. 'If it's going to take 10 or 15 years to bring a product to the market and $1 [billion] to $2 billion to do that, that's a significant investment over a long-term period. And for investors to want to do that, they have to know that there's a certain regulatory environment,' he said. 'They have to know that regulatory timelines are going to be met or exceeded.' The tariff threat: 'Our industry is a national security imperative for the country, and that means having essential medicines that patients really need manufactured here,' Bittenbender said. 'Hopefully, we won't see tariffs on the pharmaceutical industry, and we work in other ways to get manufacturing into the United States and to ensure that essential medicines that we need in times of emergency or pandemic are sourced from a place that we trust and that we know we can get them,' he added. IT'S TUESDAY. WELCOME BACK TO PRESCRIPTION PULSE. NPR reports on how music therapy can help cancer patients manage their stress and symptoms. Send your tips to David Lim (dlim@ @davidalim or davidalim.49 on Signal) and Lauren Gardner (lgardner@ @Gardner_LM or gardnerlm.01 on Signal). Eye on the FDA SECOND DMD DRUG DEATH — A second patient with Duchenne muscular dystrophy has died after taking Sarepta Therapeutics' Elevidys gene therapy, the company said, prompting a reevaluation of the drug's treatment protocol. The death occurred in a 15-year-old nonambulatory individual enrolled in the company's randomized, placebo-controlled trial intended to confirm the drug's benefit in patients who can't walk under the FDA's accelerated approval pathway. A company official said the latest death shares 'some similarities to the previous' death of a teenage boy earlier this year; both fatalities were due to acute liver failure, a known side effect of the viral vector gene therapy used in Elevidys. Sarepta said the signal has emerged only in patients who can't walk, which they consider a surrogate for disease progression. Sarepta President and CEO Douglas Ingram said the company wants to meet with the FDA 'as rapidly as possible' to establish a new immunosuppressive regimen for nonambulatory patients. Until that's implemented, the company has paused drug shipments for that population, as well as dosing for its clinical trial, it said. Response: HHS spokesperson Emily Hilliard said the FDA is treating the death 'with the highest level of concern' and 'will take all appropriate regulatory actions to protect patients during our review of gene therapy products.' The FDA is reviewing a cell therapy candidate from Capricor Therapeutics to treat DMD. The target date for a decision is Aug. 31. PDUFA PROBLEMS? KalVista Pharmaceuticals raised some eyebrows late last week after announcing that the FDA had disclosed it would miss its Tuesday PDUFA target for the drug sebetralstat, which is used as therapy for hereditary angioedema, 'due to heavy workload and limited resources.' The rare disorder causes episodes of swelling in various parts of the body and can sometimes be fatal. FDA Commissioner Marty Makary has repeatedly said medical product reviews would continue apace despite thousands of job cuts at the agency, and reviewers were not among the terminated workers. But employees charged with supporting review staff by booking travel and securing supplies were impacted, and drug companies remain concerned about attrition in the remaining workforce. HHS did not comment. In Congress EXPANDED ORPHAN EXEMPTION OUT — The Senate Finance Committee's reconciliation bill strips an effort by the House to expand a Medicare drug price negotiations exemption for orphan drugs to include medicines that treat multiple rare diseases or conditions. The Congressional Budget Office estimated the policy in the House bill would cost the federal government nearly $5 billion over 10 years, a figure groups like AARP and Patients For Affordable Drugs Now used to urge senators to keep the measure out of the Senate bill. But pharmaceutical companies argue the provision would incentivize additional investment in rare-disease drug development as the IRA exemption currently applies to orphan drugs that treat a single rare disease. SANDERS WANTS ACIP INVESTIGATION — Senate HELP ranking member Bernie Sanders (I-Vt.) wants his counterpart to open a bipartisan investigation into the removal of 17 members of the CDC's outside vaccine committee. In his letter to Sen. Bill Cassidy (R-La.), chair of the Health, Education, Labor and Pensions Committee, Sanders asked for 'serious oversight' of HHS Secretary Robert F. Kennedy Jr.'s actions regarding the Advisory Committee for Immunization Practices. 'Secretary Kennedy's reckless decision to fire these non-partisan scientific experts and replace them with ideologues with limited expertise and a history of undermining vaccines will not only endanger the lives of Americans of all ages, it directly contradicts a commitment he made to you before he was confirmed that he would not make any significant changes to this important Committee,' Sanders wrote to Cassidy. A spokesperson for Cassidy did not immediately respond to a request for comment. In the courts PURDUE SETTLEMENT 2.0 — All 50 states and several U.S. territories have agreed to sign onto a $7.4 billion settlement with Purdue Pharma and its principal owners, the Sackler family, that will resolve state and local government claims. 'The local government sign-on and voting solicitation process for this settlement moving forward will be contingent on bankruptcy court approval,' California Attorney General Rob Bonta's office said in a news release. 'A hearing is scheduled on that matter in the coming days.' The settlement ends the Sackler family's control of Purdue and prevents them from selling opioids in the country. Document Drawer The FDA's Psychopharmacologic Drugs Advisory Committee will meet on July 18 to discuss Otsuka Pharmaceutical's supplemental new drug application to approve Rexulti to treat adults with post-traumatic stress disorder in combination with sertraline. The FDA published final guidance outlining recommendations for generic drugmakers on how to submit a pre-submission facility correspondence that can be used to help the agency begin site assessments in advance of submitting an abbreviated new drug application. WHAT WE'RE READING The 17 dismissed members of the CDC's vaccine advisory panel published an op-ed in JAMA, saying their abrupt dismissal last week 'undermines the committee's capacity to operate effectively and efficiently, aside from raising questions about competence.' HHS awarded an Arizona law firm $150,000 for its expertise on the Vaccine Injury Compensation Program, NOTUS' Margaret Manto reports, suggesting it's considering policy changes to the 40-year-old system.